ArticleActa pharmacologica Sinica2026

Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway.

Long-Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.